Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Expert opinion on biological therapy·2026
Same author

Frailty in middle adulthood and associations with negative health-related outcomes in NHANES.

Aging clinical and experimental research·2026
Same author

Decentralized example of a randomized clinical trial: OM-85 use in older patients at risk of respiratory tract infections.

Aging clinical and experimental research·2026
Same author

Sarcopenia and diaphragmatic motility in patients with acute respiratory failure treated with high-flow nasal cannula and non-invasive ventilation.

European geriatric medicine·2026
Same author

A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases.

Frontiers in bioengineering and biotechnology·2026
Same author

Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength.

Metabolism: clinical and experimental·2026
Same journal

Anemia burden in tuberculosis patients across Southeast Asia: a systematic review and meta-analysis.

BMC pulmonary medicine·2026
Same journal

Airway structural involvement detected by quantitative computed tomography in controlled and uncontrolled asthma.

BMC pulmonary medicine·2026
Same journal

Serum desmosine served as a biomarker for severity and prognosis in COVID-19 patients.

BMC pulmonary medicine·2026
Same journal

Digital twins in pulmonary medicine: a scoping review of applications, benefits, and challenges.

BMC pulmonary medicine·2026
Same journal

3D CT-Based quantification of airway structural changes during asthma exacerbations: a retrospective observational study.

BMC pulmonary medicine·2026
Same journal

Conservative management of prolonged air leak following tension pneumothorax in cavitary pulmonary tuberculosis: a case report.

BMC pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Does mild COPD affect prognosis in the elderly?

Claudio Pedone1, Simone Scarlata, Claudio Sorino

  • 1Centro per la Salute dell'Anziano, Area di Geriatria, Università Campus Biomedico, Roma, Italy. c.pedone@unicampus.it

BMC Pulmonary Medicine
|June 10, 2010
PubMed
Summary
This summary is machine-generated.

Mild chronic obstructive pulmonary disease (COPD) in older adults does not appear to significantly impact independence or survival. Comorbidities and advanced age are more critical factors influencing these outcomes in elderly populations.

More Related Videos

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 12, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Area of Science:

  • Gerontology
  • Pulmonology
  • Epidemiology

Background:

  • Chronic obstructive pulmonary disease (COPD) impacts independence and survival in the general population.
  • The effect of mild COPD on independence and survival in the elderly is not well-established.
  • Investigating mild COPD across different classification systems (ATS/ERS, BTS, GOLD) in elderly individuals is crucial.

Purpose of the Study:

  • To determine if mild COPD affects personal independence and 5-year survival in elderly (65-74 years) and very elderly (≥75 years) patients.
  • To compare the impact of mild COPD based on different classification systems (ATS/ERS, BTS, GOLD).

Main Methods:

  • Utilized data from the Respiratory Health in the Elderly (SaRA) study.
  • Compared classification systems regarding personal capabilities and 5-year survival in mild COPD.
  • Focused analysis on elderly and very elderly patient cohorts.

Main Results:

  • Analyzed data from 1,159 patients (49% women, mean age 73.2 years).
  • One-third of participants were aged 75 years or older.
  • Mild COPD, irrespective of definition, showed no association with reduced personal capabilities or increased mortality after confounder adjustment in both age groups.

Conclusions:

  • Mild COPD may not significantly affect survival or independence in individuals over 65.
  • Comorbidities and advanced age are likely the primary determinants of independence and survival in the elderly.
  • The reference group's comorbidity burden is a critical consideration when evaluating mild COPD's impact.